Cargando…

A long-term follow-up of treatment for young children with obesity: a randomized controlled trial

BACKGROUND: Early childhood obesity interventions supporting parents have the largest effects on child weight status. However, long-term follow-ups are lacking. OBJECTIVE: To examine weight status 48 months after obesity treatment initiation for 4- to 6-year-olds. METHODS: 177 families were recruite...

Descripción completa

Detalles Bibliográficos
Autores principales: Ek, Anna, Brissman, Markus, Nordin, Karin, Eli, Karin, Nowicka, Paulina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599998/
https://www.ncbi.nlm.nih.gov/pubmed/37723272
http://dx.doi.org/10.1038/s41366-023-01373-7
_version_ 1785125890511863808
author Ek, Anna
Brissman, Markus
Nordin, Karin
Eli, Karin
Nowicka, Paulina
author_facet Ek, Anna
Brissman, Markus
Nordin, Karin
Eli, Karin
Nowicka, Paulina
author_sort Ek, Anna
collection PubMed
description BACKGROUND: Early childhood obesity interventions supporting parents have the largest effects on child weight status. However, long-term follow-ups are lacking. OBJECTIVE: To examine weight status 48 months after obesity treatment initiation for 4- to 6-year-olds. METHODS: 177 families were recruited to the More and Less study, a 12-month randomized controlled trial (RCT) conducted in Sweden (2012–2017); 6 children were excluded due to medical diagnoses. Thus, 171 families (non-Swedish origin 59%, university degree 40%) were eligible for this 48-month follow-up with modified intention-to-treat (n = 114 had 48-month data, n = 34 dropped out, n = 23 lost to follow-up). The RCT compared 3 treatment approaches: a 10-week parent support program (1.5 h/w) with follow-up booster sessions (PGB) or without (PGNB), and standard outpatient treatment (ST). Treatment effects on primary outcome (BMI-SDS) and secondary outcomes (BMI, %IOTF25 i.e., the distance, in percent, above the cut-off for overweight) were assessed. Clinically significant reduction of BMI-SDS (≥0.5) was assessed with risk ratio. Sociodemographic factors and attendance were examined by three-way interactions. RESULTS: After 48 months (mean 50 months, range 38–67 months) mean (95% CI) BMI-SDS was reduced in all groups: PGB −0.45 (−0.18 to −0.73, p < 0.001), PGNB −0.34 (−0.13 to −0.55, p < 0.001), ST −0.25 (−0.10 to −0.40, p < 0.001), no significant difference between groups. A clinically significant reduction of BMI-SDS ≥ 0.5 was obtained in 53.7% of PGB which was twice as likely compared to ST, 33.0%, RR 2.03 (1.27 to 3.27, p = 0.003), with no difference to PGNB, 46.6% (p = 0.113). %IOTF25 was unchanged from baseline for PGB 4.50 (−1.64 to 10.63), and significantly lower compared to ST 11.92 (8.40 to 15.44) (p = 0.043). Sociodemographics or attendance had no effect. CONCLUSION: The intensive parent-support early childhood obesity intervention led to better weight status outcomes over time, though BMI-SDS alone did not reflect this. Further research should investigate how to assess weight changes in growing children. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT01792531.
format Online
Article
Text
id pubmed-10599998
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105999982023-10-27 A long-term follow-up of treatment for young children with obesity: a randomized controlled trial Ek, Anna Brissman, Markus Nordin, Karin Eli, Karin Nowicka, Paulina Int J Obes (Lond) Article BACKGROUND: Early childhood obesity interventions supporting parents have the largest effects on child weight status. However, long-term follow-ups are lacking. OBJECTIVE: To examine weight status 48 months after obesity treatment initiation for 4- to 6-year-olds. METHODS: 177 families were recruited to the More and Less study, a 12-month randomized controlled trial (RCT) conducted in Sweden (2012–2017); 6 children were excluded due to medical diagnoses. Thus, 171 families (non-Swedish origin 59%, university degree 40%) were eligible for this 48-month follow-up with modified intention-to-treat (n = 114 had 48-month data, n = 34 dropped out, n = 23 lost to follow-up). The RCT compared 3 treatment approaches: a 10-week parent support program (1.5 h/w) with follow-up booster sessions (PGB) or without (PGNB), and standard outpatient treatment (ST). Treatment effects on primary outcome (BMI-SDS) and secondary outcomes (BMI, %IOTF25 i.e., the distance, in percent, above the cut-off for overweight) were assessed. Clinically significant reduction of BMI-SDS (≥0.5) was assessed with risk ratio. Sociodemographic factors and attendance were examined by three-way interactions. RESULTS: After 48 months (mean 50 months, range 38–67 months) mean (95% CI) BMI-SDS was reduced in all groups: PGB −0.45 (−0.18 to −0.73, p < 0.001), PGNB −0.34 (−0.13 to −0.55, p < 0.001), ST −0.25 (−0.10 to −0.40, p < 0.001), no significant difference between groups. A clinically significant reduction of BMI-SDS ≥ 0.5 was obtained in 53.7% of PGB which was twice as likely compared to ST, 33.0%, RR 2.03 (1.27 to 3.27, p = 0.003), with no difference to PGNB, 46.6% (p = 0.113). %IOTF25 was unchanged from baseline for PGB 4.50 (−1.64 to 10.63), and significantly lower compared to ST 11.92 (8.40 to 15.44) (p = 0.043). Sociodemographics or attendance had no effect. CONCLUSION: The intensive parent-support early childhood obesity intervention led to better weight status outcomes over time, though BMI-SDS alone did not reflect this. Further research should investigate how to assess weight changes in growing children. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT01792531. Nature Publishing Group UK 2023-10-25 2023 /pmc/articles/PMC10599998/ /pubmed/37723272 http://dx.doi.org/10.1038/s41366-023-01373-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ek, Anna
Brissman, Markus
Nordin, Karin
Eli, Karin
Nowicka, Paulina
A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title_full A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title_fullStr A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title_full_unstemmed A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title_short A long-term follow-up of treatment for young children with obesity: a randomized controlled trial
title_sort long-term follow-up of treatment for young children with obesity: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599998/
https://www.ncbi.nlm.nih.gov/pubmed/37723272
http://dx.doi.org/10.1038/s41366-023-01373-7
work_keys_str_mv AT ekanna alongtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT brissmanmarkus alongtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT nordinkarin alongtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT elikarin alongtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT nowickapaulina alongtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT ekanna longtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT brissmanmarkus longtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT nordinkarin longtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT elikarin longtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial
AT nowickapaulina longtermfollowupoftreatmentforyoungchildrenwithobesityarandomizedcontrolledtrial